02.11.2015 07:58:14
|
Dr. Reddy's Labs Launches Nise D Spray For Quick, Targeted Pain Killing
(RTTNews) - Dr. Reddy's Laboratories (RDY), an India-based pharmaceutical company, announced Monday the launch of Nise D Spray, further expanding the company's offerings in the therapeutic area of pain relief to consumers.
Nise D Spray offers quick and targeted pain killing. Nise will be available across all leading and neighborhood pharmacy stores. It will be available in two convenient pack sizes - pocket pack at INR 99/- and home pack for INR 130/-.
In India, the market for pain relief products is approximately 1,700 crore Indian Rupees. Pain relief sprays are growing 20 times faster than creams and gels, indicating a trend of changing consumer preferences.
The formulation for Nise D Spray comprises 3 key ingredients which get absorbed quicker, penetrate deep to reach the source of pain and reduce inflammation.
The company noted that Nise, as a brand, has been providing effective relief to consumers by killing pain over the years. Nise was the first-ever pain relief partner of the Indian Super League and various marathons in key cities across India.
M V Ramana, EVP & Head Branded Markets India & Emerging countries, said, "Nise D Spray marks our entry into the new segment and further boosts our OTC portfolio. Nise gel has made remarkable headway into the market and looking at the market dynamics and consumer requirements, we expect Nise D Spray to have a great momentum and significant market share across regions."
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Dr. Reddy's Laboratories Ltd. (Spons. ADRS)mehr Nachrichten
22.01.25 |
Ausblick: Dr Reddys Laboratories informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
08.01.25 |
Erste Schätzungen: Dr Reddys Laboratories verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
04.11.24 |
Ausblick: Dr Reddys Laboratories gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) | |
21.10.24 |
Erste Schätzungen: Dr Reddys Laboratories gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) |
Analysen zu Dr. Reddy's Laboratories Ltd. (Spons. ADRS)mehr Analysen
Aktien in diesem Artikel
Dr. Reddy's Laboratories Ltd. (Spons. ADRS) | 13,30 | 0,76% |